Pesquisa | BVS Violência e Saúde

1.

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.

Juraska, Michal; Magaret, Craig A; Shao, Jason; Carpp, Lindsay N; Fiore-Gartland, Andrew J; Benkeser, David; Girerd-Chambaz, Yves; Langevin, Edith; Frago, Carina; Guy, Bruno; Jackson, Nicholas; Duong Thi Hue, Kien; Simmons, Cameron P; Edlefsen, Paul T; Gilbert, Peter B.

Proc Natl Acad Sci U S A ; 115(36): E8378-E8387, 2018 09 04.

Artigo em Inglês | MEDLINE | ID: mdl-30127007

2.

Vaccination Against Dengue: Challenges and Current Developments.

Guy, Bruno; Lang, Jean; Saville, Melanie; Jackson, Nicholas.

Annu Rev Med ; 67: 387-404, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-26515983

3.

Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.

Henein, Sandra; Swanstrom, Jesica; Byers, Anthony M; Moser, Janice M; Shaik, S Farzana; Bonaparte, Matthew; Jackson, Nicholas; Guy, Bruno; Baric, Ralph; de Silva, Aravinda M.

J Infect Dis ; 215(3): 351-358, 2017 Feb 01.

Artigo em Inglês | MEDLINE | ID: mdl-27932620

4.

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.

Olivera-Botello, Gustavo; Coudeville, Laurent; Fanouillere, Karen; Guy, Bruno; Chambonneau, Laurent; Noriega, Fernando; Jackson, Nicholas.

J Infect Dis ; 214(7): 994-1000, 2016 10 01.

Artigo em Inglês | MEDLINE | ID: mdl-27418050

5.

Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

Glanville, Nicholas; McLean, Gary R; Guy, Bruno; Lecouturier, Valerie; Berry, Catherine; Girerd, Yves; Gregoire, Christophe; Walton, Ross P; Pearson, Rebecca M; Kebadze, Tatiana; Burdin, Nicolas; Bartlett, Nathan W; Almond, Jeffrey W; Johnston, Sebastian L.

PLoS Pathog ; 9(9): e1003669, 2013.

Artigo em Inglês | MEDLINE | ID: mdl-24086140

6.

Is discussion of dengue vaccination for the 2016 Olympics necessary?

Arredondo-García, Jose L; Hadinegoro, Sri R S; Guy, Bruno; Bouckenooghe, Alain; Noriega, Fernando; Jackson, Nicholas.

Lancet ; 388(10054): 1880-1881, 2016 Oct 15.

Artigo em Inglês | MEDLINE | ID: mdl-27751394

7.

Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains.

Balas, Claire; Kennel, Audrey; Deauvieau, Florence; Sodoyer, Regis; Arnaud-Barbe, Nadege; Lang, Jean; Guy, Bruno.

J Infect Dis ; 203(1): 103-8, 2011 Jan 01.

Artigo em Inglês | MEDLINE | ID: mdl-21148502

8.

[Tetravalent dengue vaccine development]. / Développement d'un vaccin tétravalent contre la dengue.

Guy, Bruno; Saville, Mélanie; Lang, Jean.

Virologie (Montrouge) ; 14(5): 311-321, 2010 Oct 01.

Artigo em Francês | MEDLINE | ID: mdl-36151693

9.

When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?

Guy, Bruno; Ooi, Eng Eong; Ramos-Castañeda, Jose; Thomas, Stephen J.

Vaccines (Basel) ; 8(2)2020 Apr 09.

Artigo em Inglês | MEDLINE | ID: mdl-32283639

10.

Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes.

Lecouturier, Valerie; Berry, Catherine; Saulnier, Aure; Naville, Sophie; Manin, Catherine; Girerd-Chambaz, Yves; Crowe, James E; Jackson, Nicholas; Guy, Bruno.

Vaccine ; 37(32): 4601-4609, 2019 07 26.

Artigo em Inglês | MEDLINE | ID: mdl-29706291

11.

Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection.

Bonaparte, Matthew; Zheng, Lingyi; Garg, Sanjay; Guy, Bruno; Lustig, Yaniv; Schwartz, Eli; DiazGranados, Carlos A; Savarino, Stephen; Ataman-Önal, Yasemin.

J Travel Med ; 26(8)2019 Dec 23.

Artigo em Inglês | MEDLINE | ID: mdl-31616949

12.

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

Pillet, Stéphane; Couillard, Julie; Trépanier, Sonia; Poulin, Jean-François; Yassine-Diab, Bader; Guy, Bruno; Ward, Brian J; Landry, Nathalie.

PLoS One ; 14(6): e0216533, 2019.

Artigo em Inglês | MEDLINE | ID: mdl-31166987

13.

Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses.

Trauchessec, Mathieu; Lambert, Olivier; Bonnafous, Pierre; Berard, Yves; Barriere, Fabienne; Huillet, Celine; Marco, Sergio; Sirohi, Devika; Hedrick, Victoria; Kuhn, Richard; Guy, Bruno; Ronzon, Frederic; Manin, Catherine.

Vaccine ; 37(27): 3580-3587, 2019 06 12.

Artigo em Inglês | MEDLINE | ID: mdl-31122859

14.

Towards a dengue vaccine: progress to date and remaining challenges.

Guy, Bruno; Almond, Jeffrey W.

Comp Immunol Microbiol Infect Dis ; 31(2-3): 239-52, 2008 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-17889365

15.

Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? Questions Raised by the Development and Implementation of Dengue Vaccines: Example of the Sanofi Pasteur Tetravalent Dengue Vaccine.

Guy, Bruno.

Cold Spring Harb Perspect Biol ; 10(6)2018 06 01.

Artigo em Inglês | MEDLINE | ID: mdl-28716892

16.

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).

L'Azou, Maïna; Assoukpa, Jade; Fanouillere, Karen; Plennevaux, Eric; Bonaparte, Matthew; Bouckenooghe, Alain; Frago, Carina; Noriega, Fernando; Zambrano, Betzana; Ochiai, R Leon; Guy, Bruno; Jackson, Nicholas.

Trans R Soc Trop Med Hyg ; 112(4): 158-168, 2018 04 01.

Artigo em Inglês | MEDLINE | ID: mdl-29800279

17.

Dengue vaccine prospects: a step forward.

Guy, Bruno; Almond, Jeffrey; Lang, Jean.

Lancet ; 377(9763): 381-2, 2011 Jan 29.

Artigo em Inglês | MEDLINE | ID: mdl-21277439

18.

Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4.

Deauvieau, Florence; Sanchez, Violette; Balas, Claire; Kennel, Audrey; DE Montfort, Aymeric; Lang, Jean; Guy, Bruno.

Am J Trop Med Hyg ; 76(1): 144-54, 2007 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-17255244

19.

Biodistribution and safety of a live attenuated tetravalent dengue vaccine in the cynomolgus monkey.

Ravel, Guillaume; Mantel, Nathalie; Silvano, Jeremy; Rogue, Alexandra; Guy, Bruno; Jackson, Nicholas; Burdin, Nicolas.

Vaccine ; 35(43): 5918-5923, 2017 10 13.

Artigo em Inglês | MEDLINE | ID: mdl-28882438

20.

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.

Guy, Bruno; Noriega, Fernando; Ochiai, R Leon; L'azou, Maïna; Delore, Valentine; Skipetrova, Anna; Verdier, François; Coudeville, Laurent; Savarino, Stephen; Jackson, Nicholas.

Expert Rev Vaccines ; 16(7): 1-13, 2017 07.

Artigo em Inglês | MEDLINE | ID: mdl-28590795

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: